Lepunafusp alfa

DB19011InvestigationalProtein Based Therapies

Lepunafusp alfa is under investigation in clinical trial NCT04453085 (An Extension Study of JR-171-101 Study in Patients With MPS I).

Code names
JR-171

Resolves to

Compound
UNII529C45O9XVCAS2396411-71-3

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Lepunafusp alfa, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In